Achilles Therapeutics (Achilles Therapeutics) Accounts Payable : $5.63 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Achilles Therapeutics Accounts Payable?

Achilles Therapeutics's Accounts Payable for the quarter that ended in Dec. 2023 was $5.63 Mil.

Achilles Therapeutics's quarterly Accounts Payable declined from Jun. 2023 ($6.89 Mil) to Sep. 2023 ($5.35 Mil) but then increased from Sep. 2023 ($5.35 Mil) to Dec. 2023 ($5.63 Mil).

Achilles Therapeutics's annual Accounts Payable increased from Dec. 2021 ($3.72 Mil) to Dec. 2022 ($5.19 Mil) and increased from Dec. 2022 ($5.19 Mil) to Dec. 2023 ($5.63 Mil).

Achilles Therapeutics Accounts Payable Historical Data

The historical data trend for Achilles Therapeutics's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Achilles Therapeutics Accounts Payable Chart

Achilles Therapeutics Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable

0.90

6.31

3.72

5.19

5.63

Achilles Therapeutics Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Accounts Payable	Get a 7-Day Free Trial												5.19	7.65	6.89	5.35	5.63

Achilles Therapeutics Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Achilles Therapeutics Accounts Payable Related Terms

Thank you for viewing the detailed overview of Achilles Therapeutics's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Achilles Therapeutics (Achilles Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Achilles Therapeutics PLC (NAS:ACHL) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

698:Germany

Address

245 Hammersmith Road, London, GBR, W6 8PW

Website

https://www.achillestx.com

Achilles Therapeutics PLC is a biopharmaceutical company. It is developing novel cancer immunotherapies targeting clonal neoantigens. The company has two ongoing trials, the CHIRON trial in patients with non-small-cell lung cancer and the THETIS trial in patients with recurrent or metastatic melanoma.